股本结构
单位:万股
公告日期 | 2024-03-21 | 2024-03-21 | 2023-11-13 | 2023-08-14 | 2023-06-20 | 2023-05-15 |
---|---|---|---|---|---|---|
证券总股本 | 26308.38 | 26277.59 | 26048.99 | 26050.00 | 26025.74 | 26030.00 |
普通股本 | 26308.38 | 26277.59 | 26048.99 | 26050.00 | 26025.74 | 26030.00 |
优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
变动日期 | 2024-03-20 | 2023-12-31 | 2023-09-30 | 2023-08-11 | 2023-06-12 | 2023-05-12 |
注释:中概股证券总股本=普通股股本/
存托凭证比例
历史变动
公告日期 | 变动后普通股本(万股) | 变动后优先股(万股) | 变动原因 | 变动日期 |
---|---|---|---|---|
2024-03-21 | 26308.38 | 未披露 | 定期报告 | 2024-03-20 |
2024-03-21 | 26277.59 | 未披露 |
更多>>
From December 31,2022 to December 31,2023
Share issuances
Share repurchases
Acquisition
Shares acquired and cancelled
Employee awards exercised
|
2023-12-31 |
2023-11-13 | 26048.99 | 未披露 | 定期报告 | 2023-09-30 |
2023-08-14 | 26050.00 | 未披露 | 定期报告 | 2023-08-11 |
2023-06-20 | 26025.74 | 未披露 | 定期报告 | 2023-06-12 |
2023-05-15 | 26030.00 | 未披露 | 定期报告 | 2023-05-12 |
2023-04-24 | 26010.00 | 未披露 | 定期报告 | 2023-04-19 |
2023-05-15 | 26014.41 | 未披露 | 定期报告 | 2023-03-31 |
2023-04-24 | 26049.60 | 未披露 | 定期报告 | 2023-03-01 |
2023-04-24 | 23519.42 | 未披露 |
更多>>
From December 31, 2021 to December 31, 2022
Share issuances
Share repurchases
Acquisition
Employee awards exercised
|
2022-12-31 |
2022-11-14 | 23683.34 | 未披露 | 定期报告 | 2022-09-30 |
2022-07-25 | 23799.31 | 未披露 |
更多>>
Immediately following the Meeting, the Board determined to effect the Share Consolidation on the basis of one post-consolidation Common Share for every 10 pre-consolidation Common Shares. The Share Consolidation has taken effect today, July 25, 2022, and the Common Shares are expected to begin trading on Nasdaq on a post-consolidation basis beginning at the open of markets on July 26, 2022.
|
2022-07-26 |
2022-07-25 | 237993.12 | 未披露 | 定期报告 | 2022-07-25 |
2022-05-16 | 238521.15 | 未披露 | 定期报告 | 2022-03-31 |
2022-04-28 | 206040.84 | 未披露 |
更多>>
From December 31, 2020 to December 31, 2021
Share issuances
Acquisition
Convertible debenture settlement
Derivative warrants exercised
Warrants exercised
Employee awards exercised
|
2021-12-31 |
2021-11-12 | 205599.37 | 未披露 | 定期报告 | 2021-09-30 |
2021-08-13 | 206000.00 | 未披露 | 定期报告 | 2021-08-09 |
2021-08-12 | 202888.08 | 未披露 |
更多>>
From December 31, 2020 to June 30, 2021
Share issuances
Derivative warrants exercised
Employee awards exercised
|
2021-06-30 |
2021-06-17 | 199067.57 | 未披露 | 定期报告 | 2021-06-07 |
2021-05-12 | 186000.00 | 未披露 | 定期报告 | 2021-05-11 |
2021-05-12 | 177602.48 | 未披露 |
更多>>
From December 31, 2020 to March 31, 2021
Share issuances
Derivative warrants exercised
Employee awards exercised
|
2021-03-31 |
2021-03-03 | 166022.61 | 未披露 | 定期报告 | 2021-02-25 |
2021-02-16 | 156135.27 | 未披露 | 定期报告 | 2021-02-11 |
2021-02-04 | 145916.81 | 未披露 |
更多>>
1.Series A Units offered by the company 60,500,000 Series A Units with each Series A Unit consisting of (i) one common share and (ii) one half of one Series A Warrant, with each whole Series A Warrant entitling the holder to purchase one common share.
2.Based on 1,347,418,102 common shares outstanding as of January 28, 2021.
|
2021-02-04 |
2021-02-02 | 154741.81 | 未披露 |
更多>>
1.Series A Units offered by the company 100,000,000 Series A Units with each Series A Unit consisting of (i) one common share and (ii) one half of one Series A Warrant.
2.Based on 1,347,418,102 common shares outstanding as of January 28, 2021.
|
2021-02-02 |
2021-01-29 | 134741.81 | 未披露 | 定期报告 | 2021-01-28 |
2021-01-15 | 110974.10 | 未披露 | 定期报告 | 2021-01-13 |
2021-01-11 | 103730.42 | 未披露 | 定期报告 | 2021-01-07 |
2021-03-18 | 91884.41 | 未披露 |
更多>>
from December 31, 2019 to December 31, 2020
Share issuances
Share issuance costs
Convertible debt - conversions
Derivative warrants exercised
Dispositions
Share-based compensation
Employee awards exercised
|
2020-12-31 |
2020-12-15 | 76203.88 | 未披露 | 定期报告 | 2020-12-10 |
2020-12-04 | 70676.19 | 未披露 | 定期报告 | 2020-12-01 |
2020-10-22 | 25162.74 | 未披露 | 定期报告 | 2020-10-20 |
2020-10-13 | 20671.40 | 未披露 | 定期报告 | 2020-10-02 |
2020-11-12 | 20671.39 | 未披露 |
更多>>
From June 30, 2020 to September 30, 2020
Share issuances
Share issuance costs
Convertible debt - conversions
Derivative warrants exercised
|
2020-09-30 |
2020-08-13 | 10812.76 | 未披露 | 定期报告 | 2020-08-11 |
2020-08-04 | 10614.27 | 未披露 | 定期报告 | 2020-07-28 |
2020-07-16 | 10463.71 | 未披露 | 定期报告 | 2020-07-14 |
2020-08-14 | 10463.71 | 未披露 |
更多>>
From December 31, 2019 to June 30, 2020
Share issuances
Disposition of Bridge Farm
RSUs exercised
|
2020-06-30 |
2020-06-08 | 10735.34 | 未披露 | 定期报告 | 2020-06-05 |
2020-05-15 | 10740.00 | 未披露 | 定期报告 | 2020-05-15 |
2020-04-24 | 10735.31 | 未披露 | 定期报告 | 2020-04-20 |
2020-05-15 | 10735.31 | 未披露 |
更多>>
from December 31, 2019 to March 31, 2020
Share issuances
RSUs exercised
|
2020-03-31 |
2020-03-31 | 10735.11 | 未披露 | 定期报告 | 2020-03-25 |
2020-03-31 | 10718.04 | 未披露 |
更多>>
From December 31, 2018 to December 31, 2019
Share issuances
Shares issued to related parties
Share issuance costs
Business acquisitions
Convertible debt - conversions
Warrants exercised
Share-based compensation
Employee warrants exercised
|
2019-12-31 |
2019-08-14 | 9408.15 | 未披露 | 定期报告 | 2019-08-13 |
2019-08-01 | 8380.73 | 未披露 |
更多>>
1.Common shares offered by us 11,000,000 common shares
2.The number of common shares to be outstanding after this offering includes 11,000,000 common shares to be issued in this offering (assuming the underwriters do not exercise their over-allotment option) and 72,807,315 common shares outstanding as of March 31, 2019, after giving effect to the 1 for 1.6 split of our shares
|
2019-08-01 |
2019-07-05 | 4887.83 | 未披露 | 定期报告 | 2019-06-30 |
From December 31,2022 to December 31,2023
Share issuances
Share repurchases
Acquisition
Shares acquired and cancelled
Employee awards exercised
From December 31, 2021 to December 31, 2022
Share issuances
Share repurchases
Acquisition
Employee awards exercised
Immediately following the Meeting, the Board determined to effect the Share Consolidation on the basis of one post-consolidation Common Share for every 10 pre-consolidation Common Shares. The Share Consolidation has taken effect today, July 25, 2022, and the Common Shares are expected to begin trading on Nasdaq on a post-consolidation basis beginning at the open of markets on July 26, 2022.
From December 31, 2020 to December 31, 2021
Share issuances
Acquisition
Convertible debenture settlement
Derivative warrants exercised
Warrants exercised
Employee awards exercised
From December 31, 2020 to June 30, 2021
Share issuances
Derivative warrants exercised
Employee awards exercised
From December 31, 2020 to March 31, 2021
Share issuances
Derivative warrants exercised
Employee awards exercised
1.Series A Units offered by the company 60,500,000 Series A Units with each Series A Unit consisting of (i) one common share and (ii) one half of one Series A Warrant, with each whole Series A Warrant entitling the holder to purchase one common share.
2.Based on 1,347,418,102 common shares outstanding as of January 28, 2021.
1.Series A Units offered by the company 100,000,000 Series A Units with each Series A Unit consisting of (i) one common share and (ii) one half of one Series A Warrant.
2.Based on 1,347,418,102 common shares outstanding as of January 28, 2021.
from December 31, 2019 to December 31, 2020
Share issuances
Share issuance costs
Convertible debt - conversions
Derivative warrants exercised
Dispositions
Share-based compensation
Employee awards exercised
From June 30, 2020 to September 30, 2020
Share issuances
Share issuance costs
Convertible debt - conversions
Derivative warrants exercised
From December 31, 2019 to June 30, 2020
Share issuances
Disposition of Bridge Farm
RSUs exercised
from December 31, 2019 to March 31, 2020
Share issuances
RSUs exercised
From December 31, 2018 to December 31, 2019
Share issuances
Shares issued to related parties
Share issuance costs
Business acquisitions
Convertible debt - conversions
Warrants exercised
Share-based compensation
Employee warrants exercised
1.Common shares offered by us 11,000,000 common shares
2.The number of common shares to be outstanding after this offering includes 11,000,000 common shares to be issued in this offering (assuming the underwriters do not exercise their over-allotment option) and 72,807,315 common shares outstanding as of March 31, 2019, after giving effect to the 1 for 1.6 split of our shares